219 related articles for article (PubMed ID: 25466511)
1. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.
El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS
Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.
Kaymaz Y; Oduor CI; Yu H; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
Mol Cancer Res; 2017 May; 15(5):563-576. PubMed ID: 28465297
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus and Burkitt lymphoma.
Brady G; Macarthur GJ; Farrell PJ
Postgrad Med J; 2008 Jul; 84(993):372-7. PubMed ID: 18716017
[TBL] [Abstract][Full Text] [Related]
4. Interplay between the Epigenetic Enzyme Lysine (K)-Specific Demethylase 2B and Epstein-Barr Virus Infection.
Vargas-Ayala RC; Jay A; Manara F; Maroui MA; Hernandez-Vargas H; Diederichs A; Robitaille A; Sirand C; Ceraolo MG; Romero-Medina MC; Cros MP; Cuenin C; Durand G; Le Calvez-Kelm F; Mundo L; Leoncini L; Manet E; Herceg Z; Gruffat H; Accardi R
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996097
[TBL] [Abstract][Full Text] [Related]
5. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus (EBV)-positive sporadic burkitt lymphoma: an age-related lymphoproliferative disorder?
Satou A; Asano N; Nakazawa A; Osumi T; Tsurusawa M; Ishiguro A; Elsayed AA; Nakamura N; Ohshima K; Kinoshita T; Nakamura S
Am J Surg Pathol; 2015 Feb; 39(2):227-35. PubMed ID: 25321330
[TBL] [Abstract][Full Text] [Related]
7. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas.
Piccaluga PP; Navari M; De Falco G; Ambrosio MR; Lazzi S; Fuligni F; Bellan C; Rossi M; Sapienza MR; Laginestra MA; Etebari M; Rogena EA; Tumwine L; Tripodo C; Gibellini D; Consiglio J; Croce CM; Pileri SA; Leoncini L
Oncotarget; 2016 Jan; 7(1):224-40. PubMed ID: 26325594
[TBL] [Abstract][Full Text] [Related]
8. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and
Liao HM; Liu H; Chin PJ; Li B; Hung GC; Tsai S; Otim I; Legason ID; Ogwang MD; Reynolds SJ; Kerchan P; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Ayers LW; Pfeiffer RM; Bhatia K; Goedert JJ; Lo SC; Mbulaiteye SM
Front Oncol; 2022; 12():812224. PubMed ID: 35340265
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line.
Gkiafi Z; Panayotou G
J Proteome Res; 2011 Jul; 10(7):2959-68. PubMed ID: 21615174
[TBL] [Abstract][Full Text] [Related]
13. The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma.
Lenze D; Leoncini L; Hummel M; Volinia S; Liu CG; Amato T; De Falco G; Githanga J; Horn H; Nyagol J; Ott G; Palatini J; Pfreundschuh M; Rogena E; Rosenwald A; Siebert R; Croce CM; Stein H
Leukemia; 2011 Dec; 25(12):1869-1876. PubMed ID: 21701491
[TBL] [Abstract][Full Text] [Related]
14. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines.
Hernandez-Vargas H; Gruffat H; Cros MP; Diederichs A; Sirand C; Vargas-Ayala RC; Jay A; Durand G; Le Calvez-Kelm F; Herceg Z; Manet E; Wild CP; Tommasino M; Accardi R
Sci Rep; 2017 Jul; 7(1):5852. PubMed ID: 28724958
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
[TBL] [Abstract][Full Text] [Related]
16. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
17. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
Chene A; Donati D; Orem J; Mbidde ER; Kironde F; Wahlgren M; Bejarano MT
Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
[TBL] [Abstract][Full Text] [Related]
20. A molecular link between malaria and Epstein-Barr virus reactivation.
Chêne A; Donati D; Guerreiro-Cacais AO; Levitsky V; Chen Q; Falk KI; Orem J; Kironde F; Wahlgren M; Bejarano MT
PLoS Pathog; 2007 Jun; 3(6):e80. PubMed ID: 17559303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
